Loading...
EMA scales back transparency initiatives because of workload
Author
Advisor
Date
2018-08-14
Embargo until
Language
Book title
Journal
Publisher
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Files
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Peter Doshi discusses recent changes to two of the EMA’s policies affecting access to its archives (policy 0043) and publication of new clinical data (policy 0070). The former is a permanent revision while the latter is temporary. Both policies reduce transparency by restricting access to drug data critical to independent research initiatives associated with safety, efficacy, and appropriate trial methodology.
Series/Report No.
Sponsors
Rights/Terms
Citation
Doshi, P. (2018) EMA scales back transparency initiatives because of workload. BMJ. 362:k3513. DOI: 10.1136/bmj.k3513